CIK 0001070081 · Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043416587
- Phone
- 9082227000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,752,145
- in 10 filings, $7.8M under 10b5-1 plans
Net −$7,752,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-18 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +120 | $66.49 | $8K | 70,493 |
| 2025-12-18 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −120 | $75.02 | $9K | 70,373 |
| 2025-12-18 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +251 | $18.01 | $5K | 70,624 |
| 2025-12-18 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −251 | $75.00 | $19K | 70,373 |
| 2025-12-18 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +2,831 | $66.49 | $188K | 73,204 |
| 2025-12-18 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −2,831 | $75.07 | $213K | 70,373 |
| 2025-12-18 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,951 | 19,943 | ||
| 2025-12-18 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −251 | 18,131 | ||
| 2025-12-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +1,245 | $66.49 | $83K | 74,157 |
| 2025-12-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −1,245 | $75.28 | $94K | 72,912 |
| 2025-12-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +3,684 | $18.01 | $66K | 74,157 |
| 2025-12-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −3,584 | $75.31 | $270K | 70,473 |
| 2025-12-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −100 | $76.00 | $8K | 70,373 |
| 2025-12-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +35,361 | $66.49 | $2.4M | 105,734 |
| 2025-12-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −35,261 | $75.44 | $2.7M | 70,473 |
| 2025-12-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −100 | $76.00 | $8K | 70,373 |
| 2025-12-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −36,606 | 22,894 | ||
| 2025-12-17 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,684 | 18,382 | ||
| 2025-12-16 | SCHMERTZLER MICHAEL Director | Option exercise | +24,000 | $30.86 | $741K | 155,266 |
| 2025-12-16 | SCHMERTZLER MICHAEL Director | Option exercise · Stock Option (Right to Buy) | −24,000 | 0 |
Page 15 of 25 · 493 trades